Female | Male | p | |
---|---|---|---|
All: n (%) | 718 (59.4) | 491 (40.6) | |
Altered B-CSF-B: n (%) | 150 (20.1) | 216 (44.0) | < 0.0001 |
Age 16–40 years: n (%) | 37 (11.8) | 66 (40.8) | < 0.0001 |
Age 41–60 years: n (%) | 60 (23.4) | 78 (44.3) | < 0.0001 |
Age > 60 years: n (%) | 53 (33.3) | 72 (47.1) | 0.0134 |
MS: n (%) | 204 (68.7) | 93 (31.3) | |
Altered B-CSF-B: n (%) | 15 (7.35) | 23 (24.7) | < 0.0001 |
OIND: n (%) | 132 (47.0) | 149 (53.0) | |
Altered B-CSF-B: n (%) | 60 (45.5) | 89 (59.7) | 0.0167 |
NIND: n (%) | 146 (49.2) | 151 (50.8) | |
Altered B-CSF-B: n (%) | 23 (15.8) | 50 (33.1) | 0.0005 |
UNK: n (%) | 236 (70.7) | 98 (29.3) | |
Altered B–CSF–B: n (%) | 52 (22.0) | 54 (55.1) | < 0.0001 |